The relationship between the total TRIM24 expression and the clinicopathological factors is shown in Table 1: no statistical difference was found between the TRIM24 overexpression and the characteristics of TNM stage (P = 0.108), BCLC stage (P = 0.535), gender (P = 0.614), Age (P = 0.066), Hepatitis B (P = 0.416), Tumor size (P = 0.967), Tumor amount (P = 0.277), Lymph node metastasis (P = 0.553), Tumor capsule (P = 0.337), Tumor thrombus (P = 0.103), and Cirrhosis (P = 0.065). Here, TRIM24 is linked to metastatic malignant neoplasm in the lymph nodes.